PA
CUBE icon

PharVision Advisers’s CubeSmart CUBE Stock Holding History

PharVision Advisers’s Portfolio CUBE Stock Details CUBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,599
Closed -$274K – 238
2025
Q4 		$274K Buy
+7,599
New +$289K 0.14% 331
2025
Q2 		– Sell
-10,233
Closed -$437K – 301
2025
Q1 		$437K Buy
10,233
+4,139
+68% +$173K 0.61% 23
2024
Q4 		$261K Buy
+6,094
New +$292K 0.22% 198

Other funds holding CUBE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PharVision Advisers's CUBE Position: Q1 2026 in Review

PharVision Advisers sold out of CubeSmart (CUBE) in Q1 2026, closing a stake of 7,599 shares — an estimated $274K sold.

PharVision Advisers first reported a position in CUBE in Q4 2024 and held it in 3 quarters. The position peaked at $437K in Q1 2025. 483 funds tracked by Wall St. Rank hold CUBE as of Q1 2026.

  • PharVision Advisers reported no remaining CubeSmart position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 7,599 CubeSmart shares in Q1 2026, an estimated $274K.
  • PharVision Advisers first reported a position in CubeSmart in Q4 2024 and held it in 3 quarters.
  • PharVision Advisers's CubeSmart position peaked at $437K in Q1 2025.
  • 483 funds tracked by Wall St. Rank held CubeSmart as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.